Veterinary Medicines

OVAX MGS, ενέσιμο εναιώρημα για πρόβατα

Authorised
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus inactivated bacteria
Download as PDF

Product identification

Medicine name:
OVAX MGS, ενέσιμο εναιώρημα για πρόβατα
Active substance:
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus, Inactivated
  • Staphylococcus aureus inactivated bacteria
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Staphylococcus aureus, Inactivated
    2000.00
    antigen unit(s)
    /
    1.00
    Dose
  • Staphylococcus aureus, Inactivated
    120.00
    antigen unit(s)
    /
    1.00
    Dose
  • Staphylococcus aureus inactivated bacteria
    16.00
    billion colony forming units
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 12473/10-04-1997/K-0092201
Date of authorisation status change: